Sign in

NCT03791788Completed

Multicenter Registry for Angiography-Derived Quantitative Flow Ratio

Multicenter Registry for Diagnostic Accuracy of Angiography-Derived Quantitative Flow Ratio to Evaluate the Hemodynamic Significance of Coronary Artery Stenosis

Source: ClinicalTrials.gov · Last updated 17 Apr 2024

Brief summary (registry, in English)

1. to investigate the feasibility and diagnostic performance of contrast quantitative flow ratio (QFR) for identifying the functional significance of intermediate degree stenotic lesions in all-comer patients with coronary artery disease (CAD) including presentation of acute myocardial infarction (AMI) with non-culprit lesion. 2. to compare the changes of contrast QFR and fractional flow reserve (FFR) according to severity of percent diameter stenosis (%DS) 3. to evaluate prognostic implication of contrast QFR in comparison with FFR

Status (registry)
Completed
Study type
Observational
Enrollment
524 (actual)
First submitted
28 Dec 2018
Start date
30 Apr 2016
Primary completion date
1 Oct 2022
Lead sponsor
Samsung Medical Center
NCT number
NCT03791788

What you commit to

  • Study type: Observational
  • Participants enrolled: 524
  • From 30 Apr 2016 to the primary completion date, 1 Oct 2022
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Left main (LM) or right coronary artery (RCA) ostial lesion
  • Severe overlap of stenotic segments
  • Severe tortuosity of target vessel
  • Poor angiographic image quality precluding contour detection
  • No optimal images with angles ≥ 25o

Who the study is looking for

  • Subject must be ≥18 years
  • Patients suspected with ischemic heart disease
  • Patients with intermediate degree of coronary artery stenosis (40-70% stenosis by visual estimation) in major epicardial coronary artery with FFR measurement
  • Patients who were able to analyze QFR
  • Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic evaluation and he/she or his/her legally authorized representative provides

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Keimyung University - Dongsan Medical Center
Coordinator of this site? Confirm its status
DaeguSouth KoreaUnknown status
Inje University Ilsan Paik Hospital
Coordinator of this site? Confirm its status
Goyang-siSouth KoreaUnknown status
Chosun University Hospital
Coordinator of this site? Confirm its status
GwangjuSouth KoreaUnknown status
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.